Back to GetFilings.com




UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the Quarterly Period Ended December 28, 2003

 

or

 

¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from              to             

 

Commission File No. 0-8866

 


 

MICROSEMI CORPORATION

(Exact name of registrant as specified in its charter)

 


 

Delaware   95-2110371

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

2381 Morse Avenue, Irvine, California   92614
(Address of principal executive offices)   (Zip Code)

 

(949) 221-7100

(Registrant’s telephone number, including area code)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes  x    No  ¨

 

The number of shares of the issuer’s Common Stock, $0.20 par value, outstanding on February 3, 2004 was 29,566,203 (59,432,406 as adjusted to reflect a 2-for-1 stock split to be effected by a stock dividend, the record date is February 6, 2004 and the ex-dividend date is February 23, 2004).

 



PART I - FINANCIAL INFORMATION

 

Item 1. FINANCIAL STATEMENTS

 

The unaudited consolidated income statements for the three months ended December 28, 2003 of Microsemi Corporation and Subsidiaries (“Microsemi”, “the Company”, “we”, “our”, “ours” and “us”), the unaudited consolidated statements of cash flows for the three months ended December 28, 2003, and the comparative unaudited consolidated financial information for the corresponding period of the prior year, together with our balance sheets as of December 28, 2003 (unaudited) and as of September 28, 2003, are attached hereto and incorporated herein.

 

2


MICROSEMI CORPORATION AND SUBSIDIARIES

Consolidated Balance Sheets

(amounts in thousands, except share data)

 

     September 28,
2003


    December 28,
2003


 
           (Unaudited)  

ASSETS

                

Current assets:

                

Cash and cash equivalents

   $ 29,353     $ 35,617  

Accounts receivable, net of allowance for doubtful accounts, $1,445 at September 28, 2003 and $1,454 at December 28, 2003

     28,866       28,874  

Inventories

     53,679       53,759  

Deferred income taxes

     5,239       5,239  

Other current assets

     1,234       1,507  
    


 


Total current assets

     118,371       124,996  

Property and equipment, net

     62,973       61,992  

Deferred income taxes

     10,162       10,162  

Goodwill

     3,258       3,258  

Other intangible assets, net

     6,622       6,319  

Other assets

     4,257       4,316  
    


 


TOTAL ASSETS

   $ 205,643     $ 211,043  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY

                

Current liabilities:

                

Notes payable

   $ 121     $ 121  

Current maturity of long-term debt

     89       89  

Accounts payable

     11,918       11,579  

Accrued liabilities

     14,910       15,348  

Income taxes payable

     4,165       5,299  
    


 


Total current liabilities

     31,203       32,436  
    


 


Long-term debt

     449       436  
    


 


Other long-term liabilities

     4,131       4,067  
    


 


Stockholders’ equity (see Note 10):

                

Preferred stock, $1.00 par value; authorized 1,000 shares; none issued

     —         —    

Common stock, $0.20 par value; authorized 100,000 shares; issued and outstanding 29,102 (58,204 after split) and 58,808 at September 28, 2003 and December 28, 2003, respectively

     5,821       11,763  

Capital in excess of par value of common stock

     120,134       116,091  

Retained earnings

     43,915       46,269  

Accumulated other comprehensive loss

     (10 )     (19 )
    


 


Total stockholders’ equity

     169,860       174,104  
    


 


TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

   $ 205,643     $ 211,043  
    


 


 

The accompanying notes are an integral part of these statements

 

3


MICROSEMI CORPORATION AND SUBSIDIARIES

Unaudited Consolidated Income Statements

(amounts in thousands, except earnings per share)

 

     Quarters Ended

    

December 29,

2002


   

December 28,

2003


Net sales

   $ 45,869     $ 54,945

Cost of sales

     32,840       36,763
    


 

Gross profit

     13,029       18,182
    


 

Operating expenses:

              

Selling, general and administrative

     9,017       9,707

Research and development

     4,963       4,750

Amortization of other intangible assets

     323       302

Restructuring charges

     686       —  

Loss on sale of asset, net

     428       —  
    


 

Total operating expenses

     15,417       14,759
    


 

Operating income (loss)

     (2,388 )     3,423
    


 

Other income (expense):

              

Interest, net

     (30 )     78

Other, net

     (30 )     12
    


 

Total other expense

     (60 )     90
    


 

Income (loss) before income taxes

     (2,448 )     3,513

Provision (benefit) for income taxes

     (808 )     1,159
    


 

Income (loss) before cumulative effect of a change in accounting principle

   $ (1,640 )   $ 2,354

Cumulative effect of a change in accounting principle, net of income taxes

     (14,655 )     —  
    


 

NET INCOME (LOSS)

   $ (16,295 )   $ 2,354
    


 

Basic and Diluted earnings (loss) per share (see Note 10):

              

Earnings before cumulative effect of a change in accounting principle

   $ (0.03 )   $ 0.04

Cumulative effect of a change in accounting principle

     (0.25 )     —  
    


 

Earnings (loss) per share

   $ (0.28 )   $ 0.04
    


 

Common and common equivalent shares outstanding:

              

Basic

     57,811       58,379

Diluted

     57,811       61,402

 

The accompanying notes are an integral part of these statements.

 

4


MICROSEMI CORPORATION AND SUBSIDIARIES

Unaudited Consolidated Statements of Cash Flows

(amounts in thousands)

 

     Quarters Ended

 
    

December 29,

2002


   

December 28,

2003


 

Cash flows from operating activities:

                

Net income (loss)

   $ (16,295 )   $ 2,354  

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

                

Depreciation and amortization

     2,718       2,943  

Provision for doubtful accounts

     131       24  

Loss on retirement and disposition of assets

     428       7  

Impairment of assets

     368       —    

Impairment of goodwill, net of income taxes

     14,655       —    

Changes in assets and liabilities:

                

Accounts receivable

     2,649       (32 )

Inventories

     1,258       (80 )

Other current assets

     (574 )     (156 )

Other assets

     (13 )     —    

Accounts payable

     (2,382 )     (339 )

Accrued liabilities

     52       511  

Income taxes payable

     —         1,134  

Other long-term liabilities

     14       (64 )
    


 


Net cash provided by operating activities

     3,009       6,302  
    


 


Cash flow from investing activities:

                

Purchases of property and equipment

     (2,675 )     (1,857 )

Changes in other assets

     1,268       (58 )

Proceeds from sales of assets

     2,425       —    
    


 


Net cash provided by (used in) investing activities

     1,018       (1,915 )
    


 


Cash flows from financing activities:

                

Payments of long-term debt

     (18 )     (13 )

Exercise of employee stock options

     100       1,899  
    


 


Net cash provided by financing activities

     82       1,886  
    


 


Effect of exchange rate changes on cash

     (10 )     (9 )
    


 


Net increase in cash and cash equivalents

     4,099       6,264  

Cash and cash equivalents at beginning of period

     23,060       29,353  
    


 


Cash and cash equivalents at end of period

   $ 27,159     $ 35,617  
    


 


 

The accompanying notes are an integral part of these statements.

 

5


MICROSEMI CORPORATION AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

December 28, 2003

 

1. PRESENTATION OF FINANCIAL INFORMATION

 

The financial information furnished herein is unaudited, but in the opinion of management, includes all adjustments (all of which are normal, recurring adjustments) necessary for a fair presentation of the results of operations for the periods indicated. The results of operations for the first quarter of the current fiscal year are not necessarily indicative of the results to be expected for the full year.

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q, and therefore do not include all information and footnotes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with generally accepted accounting principles. The unaudited consolidated financial statements and notes should be read in conjunction with the consolidated financial statements and notes thereto in the Annual Report on Form 10-K for the fiscal year ended September 28, 2003.

 

2. INVENTORIES

 

Inventories used in the computation of cost of goods sold were (amounts in thousands):

 

    

September 28,

2003


  

December 28,

2003


Raw materials

   $ 13,696    $ 13,623

Work in process

     25,505      26,990

Finished goods

     14,478      13,146
    

  

     $ 53,679    $ 53,759
    

  

 

3. CONTINGENCY

 

In Broomfield, Colorado, the owner of a property located adjacent to a manufacturing facility owned by a subsidiary of ours had notified the subsidiary and other parties, claiming that contaminants migrated to his property, thereby diminishing its value. In August 1995, the subsidiary, together with Coors Porcelain Company, FMC Corporation and Siemens Microelectronics, Inc., former owners of the manufacturing facility, agreed to settle the claim and to indemnify the owner of the adjacent property for remediation costs. Although TCE and other contaminants previously used at the facility are present in soil and groundwater on the subsidiary’s property, we vigorously contest any assertion that the subsidiary caused the contamination. In November 1998, we signed an agreement with three former owners of this facility whereby they 1) reimbursed us for $530,000 of past costs, 2) assume responsibility for 90% of all future clean-up costs, and 3) indemnify and protect us against any and all third-party claims relating to the contamination of the facility. An Integrated Corrective Action Plan was submitted to the State of Colorado. Sampling and management plans were prepared for the Colorado Department of Public Health & Environment. State and local agencies in Colorado are reviewing current data and considering study and cleanup options. The most recent forecast estimated that the total project cost, up to the year 2020, would be approximately $5,300,000; accordingly, we recorded a charge of $530,000 for this project in fiscal year 2003. There has not been any significant development since September 28, 2003.

 

We are involved in various pending litigation matters, arising out of the normal conduct of our business, including from time to time litigation relating to commercial transactions, contracts, and environmental matters. In the opinion of management, the final outcome of these matters will not have a material adverse effect on our financial position, results of operations or cash flows.

 

6


4. COMPREHENSIVE INCOME

 

Comprehensive income is defined as the change in equity (net assets) of a business enterprise during the period from transactions and other events and circumstances from non-owner sources. Comprehensive income consists of net income and the change of the cumulative translation adjustment. Accumulated other comprehensive loss consists of the cumulative foreign currency translation adjustment. Total comprehensive income (loss) for the quarters ended December 29, 2002 and December 28, 2003 were calculated as follows (amounts in 000’s):

 

     Quarters Ended

 
    

December 29,

2002


   

December 28,

2003


 

Net Income (loss)

   $ (16,295 )   $ 2,354  

Translation adjustment

   $ (10 )   $ (9 )
    


 


Comprehensive Income (loss)

   $ (16,305 )   $ 2,345  
    


 


 

5. EARNINGS PER SHARE

 

Basic earnings per share have been computed based upon the weighted average number of common shares outstanding during the respective periods. Diluted earnings per share have been computed, when the result is dilutive, using the treasury stock method for stock options outstanding and giving effect to issuance of shares upon conversion of debt during the respective periods.

 

On January 26, 2004, we announced a 2-for-1 stock split of shares of our common stock to be effected by means of a stock dividend. This stock split has been reflected in the following calculation of earnings per share for all periods presented (see Note 10).

 

Earnings per share (“EPS”) for the respective quarters ended December 29, 2002 and December 28, 2003 were calculated as follows (amounts in thousands, except per share data):

 

     Quarters Ended

    

December 29,

2002


   

December 28,

2003


BASIC

              

Net income (loss)

   $ (16,295 )   $ 2,354
    


 

Weighted-average common shares outstanding

     57,811       58,379
    


 

Basic earnings (loss) per share

   $ (0.28 )   $ 0.04
    


 

DILUTED

              

Net income (loss)

   $ (16,295 )   $ 2,354